Alignment Healthcare LLC (ALHC)
Official siteHEALTHCARE • HEALTHCARE PLANS • NASDAQ
Market Cap: $1.54B
Last updated: Nov 17, 2026 at 11:04 AM ET
Alignment Healthcare LLC (ALHC) P/E Ratio & Valuation History
Alignment Healthcare LLC (ALHC) trades at 37.4x trailing earnings and 0.3x sales. Its P/S of 0.3x is below its 5-year median of 0.9x. Its forward P/E is 204.1x. The median P/E across 10 similar companies is 18.9x.
Current Multiples
Its forward P/E is above its trailing P/E, which implies earnings per share about 81.7% lower over the next year. Its free cash flow yield is 11.5%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 37.4x |
| Forward P/E | 204.1x |
| Price to sales | 0.3x |
| Price to book | 5.8x |
| EV/EBITDA | 13.3x |
| Price to FCF | 8.7x |
| EV/FCF | 6.6x |
| PEG | N/A |
| FCF yield | 11.5% |
Historical Medians
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 0.3x | 0.9x | N/A |
| P/B | 5.8x | 9.4x | N/A |
Valuation History
Over the 5 year ends shown, its P/S ranged from 0.8x in 2024 to 2.1x in 2021.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $19.75 | 85.9x | 1.0x | 22.1x |
| 2024 | $11.25 | N/A | 0.8x | 21.6x |
| 2023 | $8.61 | N/A | 0.9x | 10.3x |
| 2022 | $11.76 | N/A | 1.5x | 9.0x |
| 2021 | $14.06 | N/A | 2.1x | 8.2x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About ALHC
What is ALHC's forward P/E ratio?
Alignment Healthcare LLC has a forward P/E ratio of 204.1x.
Is ALHC stock overvalued?
GNG's valuation label for ALHC is Undervalued. Its P/E of 37.4x compares with a median of 18.9x across 10 similar companies.
What is ALHC's price to sales ratio?
Alignment Healthcare LLC has a price to sales ratio of 0.3x.
ALHC pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors